<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">FASEB J</journal-id>
<journal-id journal-id-type="iso-abbrev">FASEB J</journal-id>
<journal-id journal-id-type="pmc">fasebj</journal-id>
<journal-id journal-id-type="publisher-id">fasebj</journal-id>
<journal-title-group>
<journal-title>The FASEB Journal</journal-title>
</journal-title-group>
<issn pub-type="ppub">0892-6638</issn>
<issn pub-type="epub">1530-6860</issn>
<publisher>
<publisher-name>Federation of American Societies for Experimental Biology</publisher-name>
<publisher-loc>Bethesda, MD, USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30698461</article-id>
<article-id pub-id-type="pmc">6436650</article-id>
<article-id pub-id-type="publisher-id">FJ_201801110RR</article-id>
<article-id pub-id-type="doi">10.1096/fj.201801110RR</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Overexpression of <italic>NEUROG2</italic> and <italic>NEUROG1</italic> in human embryonic stem cells produces a network of excitatory and inhibitory neurons</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Lu</surname>
<given-names>Congyi</given-names>
</name>
<xref ref-type="aff" rid="aff1">*</xref>
<xref ref-type="aff" rid="aff2">
<sup>†</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>‡</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>§</sup>
</xref>
<xref ref-type="author-notes" rid="afn1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shi</surname>
<given-names>Xi</given-names>
</name>
<xref ref-type="aff" rid="aff1">*</xref>
<xref ref-type="aff" rid="aff3">
<sup>‡</sup>
</xref>
<xref ref-type="author-notes" rid="afn1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Allen</surname>
<given-names>Andrew</given-names>
</name>
<xref ref-type="aff" rid="aff1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Baez-Nieto</surname>
<given-names>David</given-names>
</name>
<xref ref-type="aff" rid="aff1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nikish</surname>
<given-names>Alexandria</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>¶</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sanjana</surname>
<given-names>Neville E.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>†</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>§</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pan</surname>
<given-names>Jen Q.</given-names>
</name>
<xref ref-type="aff" rid="aff1">*</xref>
<xref ref-type="corresp" rid="cor1">
<sup>2</sup>
</xref>
</contrib>
<aff id="aff1"><label>*</label>Stanley Center for Psychiatric Research, Broad Institute, Cambridge, Massachusetts, USA;</aff>
<aff id="aff2"><label>†</label>New York Genome Center, New York, New York, USA;</aff>
<aff id="aff3"><label>‡</label>McGovern Institute for Brain Research, Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts, USA;</aff>
<aff id="aff4"><label>§</label>Department of Biology, New York University, New York, New York, USA;</aff>
<aff id="aff5"><label>¶</label>Department of Biological Engineering, Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts, USA</aff>
</contrib-group>
<author-notes>
<fn fn-type="equal" id="afn1">
<label>1</label>
<p>These authors contributed equally to this work.</p>
</fn>
<corresp id="cor1"><label>2</label>Correspondence: <addr-line>Stanley Center for Psychiatric Research, Broad Institute, 75 Ames St., Cambridge, MA 01720, USA.</addr-line> E-mail: <email>jpan@broadinstitute.org</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>4</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>30</day>
<month>1</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>1</day>
<month>4</month>
<year>2020</year>
</pub-date>
<!-- PMC Release delay is 12 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>33</volume>
<issue>4</issue>
<fpage>5287</fpage>
<lpage>5299</lpage>
<history>
<date date-type="received">
<day>14</day>
<month>6</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>02</day>
<month>1</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© FASEB</copyright-statement>
<copyright-year>2019</copyright-year>
<copyright-holder>FASEB</copyright-holder>
</permissions>
<self-uri content-type="pdf" xlink:href="fj.201801110RR.pdf"></self-uri>
<abstract>
<p>Overexpression of mouse neurogenin (<italic>Neurog</italic>)<italic>2</italic> alone or in combination with mouse <italic>Neurog2/1</italic> in human embryonic stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs) can rapidly produce high-yield excitatory neurons. Here, we report a detailed characterization of human neuronal networks induced by the expression of human <italic>NEUROG2</italic> together with human <italic>NEUROG2/1</italic> in hESCs using molecular, cellular, and electrophysiological measurements over 60 d after induction. Both excitatory synaptic transmission and network firing activity increased over time. Strikingly, inhibitory synaptic transmission and GABAergic cells were identified from <italic>NEUROG2/1</italic> induced neurons (iNs). To illustrate the application of such iNs, we demonstrated that the heterozygous knock out of <italic>SCN2A</italic>, whose loss-of-function mutation is strongly implicated in autism risk, led to a dramatic reduction in network activity in the <italic>NEUROG2/1</italic> iNs. Our findings not only extend our understanding of the <italic>NEUROG2/1-</italic>induced human neuronal network but also substantiate <italic>NEUROG2/1</italic> iNs as an <italic>in vitro</italic> system for modeling neuronal and functional deficits on a human genetic background.—Lu, C., Shi, X., Allen, A., Baez-Nieto, D., Nikish, A., Sanjana, N. E., Pan, J. Q. Overexpression of <italic>NEUROG2</italic> and <italic>NEUROG1</italic> in human embryonic stem cells produces a network of excitatory and inhibitory neurons.</p>
</abstract>
<kwd-group>
<kwd>neurogenin</kwd>
<x xml:space="preserve"> • </x>
<kwd>induced neuronal network</kwd>
<x xml:space="preserve"> • </x>
<kwd>GABAergic</kwd>
<x xml:space="preserve"> • </x>
<kwd>
<italic>SCN2A</italic>
</kwd>
</kwd-group>
<counts>
<fig-count count="8"></fig-count>
<table-count count="0"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="40"></ref-count>
<page-count count="13"></page-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name> SJS Export </meta-name>
<meta-value>v1</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
</article>
</pmc-articleset>